
Tufdrox CV 250mg/62.5mg Tablet DT
Marketer
Abbott
Salt Composition
Cefadroxil (250mg) + Clavulanic Acid (62.5mg)
Overview Tufdrox CV 250mg/62.5mg Tablet DT
Combiflox 250mg/62.5mg Delayed-Release Tablets contain a dual-action formulation to combat diverse bacterial infections. This medication inhibits microbial proliferation and spread. Always adhere to your physician's prescribed dosage and schedule; consistent timing maximizes effectiveness. Never exceed the recommended dose; doing so can be detrimental. If a dose is missed, take it promptly upon recollection. Complete the entire course of treatment, even if symptoms improve; premature cessation compromises its efficacy. Minor side effects such as nausea, vomiting, diarrhea, and dyspepsia may occur. Report worsening side effects immediately to your doctor. Seek immediate medical attention for allergic reactions (including rash, pruritus, edema, or dyspnea). Inform your doctor of all current medications, especially if you are pregnant, breastfeeding, or have pre-existing conditions before starting this treatment. Alcohol consumption may increase drowsiness; avoid concurrent use. While generally non-impairing, refrain from driving if drowsiness or dizziness occurs.
Uses of Tufdrox CV 250mg/62.5mg Tablet DT
Managing bacterial infections
Major Benefits of Tufdrox CV 250mg/62.5mg Tablet DT:
Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Dissolve the Tufdrox CV 250mg/62.5mg Tablet DT in water before consumption. While it can be taken with or without food, consistent daily timing is recommended.
How to use Tufdrox CV 250mg/62.5mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve one tablet in water before consumption. While Tufdrox CV 250mg/62.5mg Tablet DT can be ingested with or without food, consistent timing is recommended for optimal results.
How Tufdrox CV 250mg/62.5mg Tablet DT works:
Cefadroxil and Clavulanic Acid, combined as Tufdrox CV 250mg/62.5mg Delayed-Release Tablets, offer targeted antibacterial action. Cefadroxil, an antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Clavulanic Acid, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise neutralize Cefadroxil. This synergistic effect broadens Cefadroxil's effectiveness by overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Tufdrox CV 250mg/62.5mg Tablet DT and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The use of Tufdrox CV 250mg/62.5mg Delayed-Release Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Tufdrox CV 250mg/62.5mg delayed-release tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Tufdrox CV 250mg/62.5mg Tablet DT, including allergic reactions, dizziness, or seizures.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Tufdrox CV 250mg/62.5mg Tablet DT. Dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Using Tufdrox CV 250mg/62.5mg Tablet DT in patients with liver conditions appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Tufdrox CV 250mg/62.5mg Tablet DT :
Should you forget to take a Tufdrox CV 250mg/62.5mg DT tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Tufdrox CV 250mg/62.5mg Tablet DT
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Antimicrobial Agents |
